LABODENTAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LABODENTAL
Largest movements
- Receivables within one year -€1,096
down €1,096 (-31.1%), from €3,524 to €2,428
- Profit (loss) carried forward -€1,149
down €1,149 (-13.1%), from -€8,754 to -€9,903
- Trade debts +€50
up €50 (+3.9%), from €1,281 to €1,331
- Gross operating margin -€545
new in 2024: -€545
- Financial charges +€121
up €121 (+43.9%), from €276 to €398
- Financial income +€42
up €42 (+30.6%), from €138 to €180
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,527 | €2,428 | -€1,099 | -31.2% |
| Current assets | 29/58 | €3,527 | €2,428 | -€1,099 | -31.2% |
| Amounts receivable within one year | 40/41 | €3,524 | €2,428 | -€1,096 | -31.1% |
| Other amounts receivable | 41 | €3,524 | €2,428 | -€1,096 | -31.1% |
| Cash at bank and in hand | 54/58 | €3 | €0 | -€3 | -87.2% |
| Total equity and liabilities | 10/49 | €3,527 | €2,428 | -€1,099 | -31.2% |
| Equity | 10/15 | €2,246 | €1,097 | -€1,149 | -51.2% |
| Contributions | 10/11 | €11,000 | €11,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€8,754 | -€9,903 | -€1,149 | -13.1% |
| Amounts payable | 17/49 | €1,281 | €1,331 | +€50 | +3.9% |
| Amounts payable within one year | 42/48 | €1,281 | €1,331 | +€50 | +3.9% |
| Trade debts | 44 | €1,281 | €1,331 | +€50 | +3.9% |
| Suppliers | 440/4 | €1,281 | €1,331 | +€50 | +3.9% |
| Other operating charges | 640/8 | €384 | €387 | +€3 | +0.8% |
| Gross operating margin | 9900 | - | -€545 | -€545 | |
| Operating profit (loss) | 9901 | -€384 | -€932 | -€547 | -142% |
| Financial income | 75/76B | €138 | €180 | +€42 | +30.6% |
| Recurring financial income | 75 | €138 | €180 | +€42 | +30.6% |
| Financial charges | 65/66B | €276 | €398 | +€121 | +43.9% |
| Recurring financial charges | 65 | €276 | €398 | +€121 | +43.9% |
| Profit (loss) for the period before taxes | 9903 | -€523 | -€1,149 | -€626 | -120% |
| Profit (loss) for the period | 9904 | -€523 | -€1,149 | -€626 | -120% |
| Profit (loss) for the period to be appropriated | 9905 | -€523 | -€1,149 | -€626 | -120% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.